CG
AYTU icon

Cutler Group’s AYTU BioPharma AYTU Stock Holding History

Cutler Group’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46
Closed -$5K – 5605
2020
Q4 		$5K Buy
46
+25
+119% +$4.55K ﹤0.01% 3616
2020
Q3 		$4K Hold
21
– – ﹤0.01% 3606
2020
Q2 		$5K Buy
+21
New +$6.36K ﹤0.01% 3269
2019
Q1 		– Hold
0
– – – 4014
2018
Q4 		– Hold
0
– – – 3917
2018
Q3 		– Hold
0
– – – 4075
2018
Q2 		– Hold
0
– – – 4174
2018
Q1 		– Hold
0
– – – 4429
2017
Q4 		– Hold
0
– – – 4878

Other funds holding AYTU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cutler Group's AYTU Position: Q1 2021 in Review

Cutler Group sold out of AYTU BioPharma (AYTU) in Q1 2021, closing a stake of 46 shares — an estimated $5K sold.

Cutler Group first reported a position in AYTU in Q2 2020 and held it in 3 quarters. The position peaked at $5K in Q4 2020. 64 funds tracked by Wall St. Rank hold AYTU as of Q1 2021.

  • Cutler Group reported no remaining AYTU BioPharma position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 46 AYTU BioPharma shares in Q1 2021, an estimated $5K.
  • Cutler Group first reported a position in AYTU BioPharma in Q2 2020 and held it in 3 quarters.
  • Cutler Group's AYTU BioPharma position peaked at $5K in Q4 2020.
  • 64 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.